The role of Aβ42 in Alzheimer's disease

被引:232
|
作者
Younkin, SG [1 ]
机构
[1] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA
关键词
amyloid; senile plaques; cholinergic system; familial Alzheimer's disease linked mutations;
D O I
10.1016/S0928-4257(98)80035-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Our recent studies of plasma, fibroblasts, transfected cells and transgenic mice show that a fundamental effect of the mutations linked to familial Alzheimer's disease (FAD) is to increase the extracellular concentration of A beta 42. This effect of the FAD-linked mutations is likely to be directly related to the pathogenesis of Alzheimer's disease (AD) because A beta 42 is deposited early and selectively in the senile plaques that are an invariant feature of all forms of AD. Thus our results provide strong evidence that the FAD-linked mutations all cause AD by increasing the extracellular concentration of A beta 42 (43), thereby fostering A beta deposition, and they support the hypothesis that cerebral A beta deposition is an essential early event ir. the pathogenesis of all forms of AD. Interactions between the basal forebrain cholinergic system and A beta that could influence AD pathogenesis are discussed. ((C)Elsevier, Paris).
引用
收藏
页码:289 / 292
页数:4
相关论文
共 50 条
  • [1] Presenilins and Alzheimer's disease:: the role of Aβ42
    Eckman, CB
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 181 - 184
  • [2] The role of amyloid β peptide 42 in Alzheimer's disease
    Findeis, Mark A.
    PHARMACOLOGY & THERAPEUTICS, 2007, 116 (02) : 266 - 286
  • [3] Aβ42, presenilins, and Alzheimer's disease
    Iwatsubo, T
    NEUROBIOLOGY OF AGING, 1998, 19 (01) : S11 - S13
  • [4] The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease
    Tamagno, Elena
    Guglielmotto, Michela
    Monteleone, Debora
    Manassero, Giusi
    Vasciaveo, Valeria
    Tabaton, Massimo
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1241 - 1245
  • [5] Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
    Lista, Simone
    Emanuele, Enzo
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 411 - 413
  • [6] Oligomeric Aβ42 levels in Alzheimer's disease
    van Helmond, Z.
    Miners, S.
    Ashby, E.
    Kehoe, P. G.
    Love, S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2008, 34 : 2 - 2
  • [7] A β-42 peptide lowering NSAIDs and Alzheimer's disease
    Breteler, MMB
    Veld, BIH
    Hofman, A
    Stricker, BHC
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S286 - +
  • [8] Significance of intracellular Aβ42 accumulation in Alzheimer's disease
    Tabira, T
    Chui, DH
    Kuroda, S
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : A44 - A49
  • [9] CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer's Disease and Frontotemporal Dementias
    Constantinides, Vasilios C.
    Paraskevas, George P.
    Boufidou, Fotini
    Bourbouli, Mara
    Pyrgelis, Efstratios-Stylianos
    Stefanis, Leonidas
    Kapaki, Elisabeth
    DIAGNOSTICS, 2023, 13 (04)
  • [10] Protective role of Cordyceps militaris in Aβ1–42-induced Alzheimer’s disease in vivo
    Mei Tong He
    Ah Young Lee
    Ji Hyun Kim
    Chan Hum Park
    Yu Su Shin
    Eun Ju Cho
    Food Science and Biotechnology, 2019, 28 : 865 - 872